# Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation

> **NCT01732692** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 140 (actual)

## Conditions studied

- Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.

## Interventions

- **DRUG:** MOVIPREP

## Key facts

- **NCT ID:** NCT01732692
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2014-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732692, "Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01732692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*